Recommended Alerts

Sign Up For Alerts

The Application of the UK’s NSIA to Life Sciences Transactions

The UK’s National Security and Investments Act (“NSIA”) came into force today, granting the UK Government, through the Department for Business, Energy & Industrial Strategy (“BEIS”), the power to review transactions that may give rise to a national security risk.

Read More

Sorrell v. IMS Health Inc. — Supreme Court Strikes Down Law Restricting Pharmaceutical Manufacturers’ Speech

Practices: Life Sciences, Health Care, Government Enforcement / White Collar Crime Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

Cookie Settings